Legal Forum: Responding to the Avian Flu Threat: Balancing Risks and Rewards - Vaccine development holds the greatest promise and the greatest challenge for protecting the worldwide population from an

ADVERTISEMENT

Legal Forum: Responding to the Avian Flu Threat: Balancing Risks and Rewards
Vaccine development holds the greatest promise and the greatest challenge for protecting the worldwide population from an avian flu pandemic


BioPharm International
Volume 19, Issue 2

8. Slater (2004), "Industry and Government Perspective in Influenza Control," Texas Heart Inst. J. 31:42-44.

9. Coyle (2005), "Consumer Groups Slam Vaccine Bill," National Law Journal Dec. 13, 2005.

10. Trivalent influenza vaccines were added to the VICP in July 2005, see http://www.hrsa.gov/osp/vicp/

11. See Coyle (2005), supra.

12. Section 6 of S. 1878, the Biodefense and Pandemic Vaccine and Drug Development Act of 2005.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

GPhA Issues Statement on Generic Drug Costs
November 20, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
Manufacturing Issues Crucial to Combating Ebola
November 20, 2014
FDA Requests Comments on Generic Drug Submission Criteria
November 20, 2014
USP Joins Chinese Pharmacopoeia Commission for Annual Science Meeting
November 20, 2014
Author Guidelines
Source: BioPharm International,
Click here